|
Cancer research in Northwestern
Ontario continues to set the course for innovation.
June 28, 2006
The Northern Cancer Research Foundation is proud to announce
a 2006 instalment of $60,000 towards innovative medical physics
cancer research conducted here in Thunder Bay. This grant
announcement serves to bolster the research contributing to
the growing molecular medicine critical mass in Northern Ontario.
Dr. Sylvie Landry, Medical Physics Project Coordinator, Dr.
Peter McGhee, Director of Medical Physics, and Dr. Werden
Keeler, Professor Emertius at Lakehead University, have engaged
a research pathway that will ultimately contribute to individualization
of cancer treatment. With support from the NCRF, the Medical
Physics Research Laboratory (MPRL) was established in February
2002, with the arrival of Dr. Sylvie Landry. Her arrival combined
with the collaborative efforts of MPRL facilitated research
on ‘treated live cell imaging’. Currently, Dr.
Landry and her two collaborators have developed a novel system
that allows the imaging of live cells over tens of hours compared
with the previous maximum of a few hours by using Oblique
Incidence Reflection (OIR) Microscopy.
 |
“Our cancer research scientists continue to
set the bar higher with every new undertaking and success,”
said Michael Power, Vice President, Regional Cancer
and Diagnostics. “The efforts of this collaborative
team have effected pivotal change in our region. Their
research primarily contributes to the foundation for
a future economic engine that will drive Northwestern
Ontario into a new era of opportunity and development.” |
 |
The role of light and lasers in the diagnosis and
treatment of cancer continues to evolve as both basic
physical understanding and technological development
present new opportunities. Some techniques, such as
Raman spectroscopy, are well established outside the
context of cancer research and treatment. Other techniques,
such as multiple photon excitation, are in relative
infancy of development, and hold promise of current
unachievable capabilities. In collaboration with the
Physics Department of Lakehead University, the MPRL
has embarked upon several investigations, its primary
focus to treat live cells with light over an extended
course of time. “The research in this field to
date has had sporadic results, as the techniques have
generated some phototoxicity, photobleaching, and invasive
manipulations of the cells, thereby compromising the
integrity of the cell,” said Dr. Peter McGhee,
Director, Medical Physics. “We have been working
with our OIR Microscopy, a minimally invasive approach
which allows us to view the cells over long periods
of time. This has the potential to show us the effects
that cytotoxic chemicals (chemotherapy) or ionizing
radiation have on the cells, and the efficacy of our
treatments for individual patients.” |
 |
Live cell imaging techniques typically involve taking
several short exposures per minute over several hours.
It is crucial to prevent cell damage caused by the illumination
source while monitoring cellular activity. In the ongoing
experimentation in the MPRL, scientists have realized
success in the OIR approach, which has no previously
published record of use in this type of cellular activity
monitoring. “We have conquered an enormous obstacle
in this research thus far,” stated Dr. Werden
Keeler, Professor Emeritus, Experimental Biological
and Optical Physics, Lakehead University. “The
challenge with our course of research to date has been
the current approach with fluorescence illumination,
which only provides a few hours of cell viability before
the cell cultures become damaged. Our approach has yielded
live cell viability for up to 20 hours at one time,
allowing us to study cell morphology in both treated
cells and healthy untreated cells for an extended period
of time. This gives us another sizable puzzle piece
in the pursuit to understand cancer cell dynamics.” |
 |
To date, the NCRF has provided more than $434,000
towards research conducted in this arena. Research such
as this generates excitement in the medical and academic
fields as well as the community. “Northwestern
Ontario should be incredibly proud of this research
as this region is entirely responsible for its funding,”
said Glenn Craig, President and CEO, NCRF. “It’s
very exciting to see the tangible results of projects
funded by this community’s generosity. This kind
of research furthers our understanding of cancer, and
the NCRF is honoured to assist in enabling that process.
We are dedicated to providing funds that stay here in
Northwestern Ontario, with the specific goal of improving
patient care, furthering research, and stimulating education
and awareness for the residents of our region and community.” |
::
back to Media Releases ::
|
|